Ronald Fisher Is Not Being ‘Cancelled’, But His Eugenic Advocacy Should Have Consequences
By Eric Michael Johnson,
This View of Life
| 04. 12. 2021
Photo by Schutz, stained glass designed by Maria McClafferty,
CC BY-SA 2.5, via Wikimedia Commons
While Black Lives Matter protests raged and confederate statues were toppled across the United States following the killing of George Floyd, the quiet removal of a stained-glass window at Cambridge University closed one chapter in the history of scientific racism. On June 26, 2020, a commemorative window in honor of the statistician, geneticist, and evolutionary biologist Ronald Aylmer Fisher was targeted for removal from Gonville and Caius College where he had lived during his time at Cambridge.1 A student petition that had received more than 1,400 signatures objected to Fisher’s “endorsements of colonialism, white supremacy and eugenics.”2 Following a review, the College Council decided to support the students with a statement acknowledging Fisher’s fundamental contributions to statistics and genetics but concluded that honoring him would not constitute a welcoming environment given that he was “a prominent proponent of eugenics, both in his scientific work and his public pronouncements throughout his career.”3 Other organizations, such as the Society for the Study of Evolution...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...